Quoin Pharmaceuticals Ltd.
QNRX | NASDAQ
$7.23
+$0.33 (+4.78%)
Sep 22, 2026, 10:32 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 25.43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -25.43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -19.24M | -17.46M | -16.29M | -14.18M | -12.68M | -11.03M | -9.53M | -9.34M | -8.94M | -9.06M | -9.38M | -9.25M | -9.45M | -9.86M | -9.26M | -10.15M | -9.13M | -7.44M | -6.06M | -3.67M | -2.7M | -2.07M |
Interest Income | 483.42K | 486.13K | 484.23K | 421.86K | 505.98K | 565.85K | 558.49K | 607.71K | 657.75K | 680.07K | 694.61K | 616.68K | 435.39K | 247.8K | 95.75K | 15.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -18.76M | -16.99M | -15.8M | -13.77M | -12.17M | -10.45M | -8.96M | -8.7M | -8.28M | -8.41M | -8.69M | -8.64M | -9.74M | -10.3M | -9.38M | -19.2M | -17.57M | -19.24M | -21.46M | -10.66M | -9.59M | -5.6M |
Net Income | -18.76M | -16.99M | -15.8M | -13.77M | -12.17M | -10.45M | -8.96M | -8.7M | -8.28M | -8.41M | -8.69M | -8.64M | -9.74M | -10.3M | -9.38M | -19.2M | -17.57M | -19.24M | -21.46M | -10.66M | -9.59M | -5.6M |
Selling & General & Admin | 6.74M | 6.6M | 6.49M | 6.4M | 6.02M | 5.83M | 5.82M | 5.87M | 5.87M | 5.96M | 6.07M | 6.16M | 6.37M | 6.68M | 6.58M | 7.09M | 6.55M | 5.34M | 4.5M | 3M | 2.26M | 1.85M |
Research & Development | 12.48M | 10.86M | 9.8M | 7.78M | 6.67M | 5.2M | 3.71M | 3.48M | 3.06M | 3.1M | 3.31M | 3.09M | 3.08M | 3.18M | 2.67M | 3.07M | 2.58M | 2.09M | 1.56M | 672.3K | 438.31K | 225.04K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 19.21M | 17.46M | 16.29M | 14.18M | 12.68M | 11.03M | 9.53M | 9.34M | 8.94M | 9.06M | 9.38M | 9.25M | 9.45M | 9.86M | 9.26M | 10.15M | 9.13M | 7.44M | 6.06M | 3.67M | 2.7M | 2.07M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 714.08K | 714.08K | 714.08K | 1.29M | 822.3K | 1.02M | 1.09M | 563.3K | 315.13K | 112.62K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.24M | 17.46M | 16.29M | 14.18M | 12.68M | 11.03M | 9.53M | 9.34M | 8.94M | 9.06M | 9.38M | 9.25M | 9.45M | 9.86M | 9.26M | 10.15M | 9.13M | 7.44M | 6.06M | 3.67M | 2.7M | 2.07M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.01M | 2.83M | 1.5M | 588.17K | 588.17K | 586.33K | 186.51K | 5M | 5.05M | 2.1M | 987.22K | 987.22K | 987.22K | 987.22K | 403.88K | 274.37K | 274.37K | 55.91K | 45K | 20K | 20K | 20K |
Shares Outstanding (Diluted) | 2.01M | 2.83M | 1.5M | 588.17K | 588.17K | 586.33K | 186.51K | 5M | 5.05M | 2.1M | 987.22K | 987.22K | 987.22K | 987.22K | 403.88K | 274.37K | 274.37K | 55.92K | 45.2K | 20.03K | 20.03K | 20.03K |
EPS (Basic) | -14.12 | -17.68 | -22.41 | -31.86 | -41.60 | -35.71 | -30.33 | -20.06 | -5.56 | -7.30 | -8.60 | -11.39 | -23.08 | -30.67 | -49.53 | -476.86K | -476.91K | -477.12K | -477.29K | -495.01 | -441.21 | -241.84 |
EPS (Diluted) | -14.12 | -17.68 | -22.41 | -31.90 | -41.64 | -35.75 | -30.37 | -20.06 | -5.56 | -7.30 | -8.60 | -11.39 | -23.08 | -30.67 | -49.52 | -474.7K | -474.76K | -474.97K | -475.14K | -494.32 | -440.62 | -241.56 |
EBITDA | -18.91M | -17.04M | -15.7M | -13.67M | -12.07M | -10.35M | -8.86M | -8.6M | -8.18M | -8.31M | -8.58M | -8.53M | -8.92M | -9.48M | -8.56M | -17.81M | -16.65M | -18.11M | -20.27M | -10M | -9.17M | -5.38M |
EBIT | -18.98M | -17.11M | -15.8M | -13.77M | -12.17M | -10.45M | -8.96M | -8.7M | -8.28M | -8.41M | -8.69M | -8.64M | -9.03M | -9.59M | -8.67M | -17.91M | -16.75M | -18.22M | -20.37M | -10.1M | -9.27M | -5.49M |
Depreciation & Amortization | 75.43K | 75K | 100K | 100K | 100K | 100K | 100K | 100.67K | 101.68K | 102.7K | 103.71K | 104.04K | 104.04K | 104.04K | 104.04K | 104.04K | 104.04K | 104.04K | 104.04K | 104.04K | 104.04K | 104.04K |
Add to Watchlist
Select watchlists to add or remove QNRX